From July 1, 2022 to September 30, 2022, the company has repurchased 1,631,700 shares, representing 0.14% for CNY 32.03 million. With this, the company has completed the repurchase of 9,199,916 shares, representing 0.79% for CNY 200.16 million under the buyback announced on May 5, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.55 CNY | -1.77% | -0.58% | +1.04% |
Apr. 17 | Apeloa Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 10 | Apeloa Pharmaceutical Co.,Ltd Approves Cash Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.04% | 2.56B | |
+32.09% | 694B | |
+29.39% | 593B | |
-1.34% | 371B | |
+20.34% | 331B | |
+7.39% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.49% | 169B |
- Stock Market
- Equities
- 000739 Stock
- News Apeloa Pharmaceutical Co.,Ltd
- Tranche Update on Apeloa Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on May 5, 2022.